In-House Insights: Managing Legal Strategy in Cross-Border Biotech
CEO and General Counsel of MyoMed Bio, explains how legal strategy—spanning IP, regulatory compliance, and cross-border structuring—is essential for enabling clinical development, managing geopolitical and data protection risks, and aligning biotech operations across China, the U.S., and Australia.
Latest News
More News
In the News: US Takes Steps to Tighten Listing Rules; Outbound Investment Cap Lifted; and EU Restricts Market Access For Chinese Medical Device Manufacturers
Legislation roundup: Monopoly agreements, Material asset restructurings and Trust companies
The Impact of the US Executive Order on Drug Pricing on Chinese Companies
Generative AI in China and the EU: What Businesses Need to Know
Features & Analyses
More Features & Analyses
Comments on the New CAC Data Transfer Q&A
April 24, 2025
Full Text Translations
More Full Text Translations
-
Interpretation of Several Issues Concerning the Application of the Law in the Handling of Criminal Intellectual Property Infringement Cases
关于办理侵犯知识产权刑事案件适用法律若干问题的解释
SPC defines “same kind of good or service” in criminal IP cases / CLP Reference: 5100/25.04.23 ; Promulgated: 2025-04-23 ; Effective: 2025-04-26
-
Q&A on Policies for Administration of the Security of Overseas Data Transfers
数据出境安全管理政策问答
CAC defines the necessity for overseas transfer of personal data
-
Measures for Labeling Synthetic Content Generated by Artificial Intelligence
人工智能生成合成内容标识办法
A service provider that provides online information content propagation services is required to verify AI labeling / CLP Reference: 5600/25.03.07 ; Promulgated: 2025-03-07 ; Effective: 2025-09-01
-
Guidelines for Compliance Audits of Personal Information Protection
个人信息保护合规审计指引
A compliance audit is required when processing personal information of more than 10 million persons / CLP Reference: 5600/25.02.12 ; Promulgated: 2025-02-12; Effective: 2025-05-01
-
Measures for the Administration of Compliance Audits of Personal Information Protection
个人信息保护合规审计管理办法
A compliance audit is required when processing personal information of more than 10 million persons / CLP Reference: 5600/25.02.12 ; Promulgated: 2025-02-12; Effective: 2025-05-01
Law Digests
More Law Digests
-
State Administration for Market Regulation, Provisions for the Protection of Trade Secrets (Draft for Comments)
国家市场监督管理总局商业秘密保护规定 (征求意见稿)
SAMR clarifies the “appropriate confidentiality measures” in trade secrets protection / Issued: 2025-04-25
-
State Administration for Market Regulation, Provisions for Curbing Acts of Abusing Administrative Power to Eliminate or Restrict Competition (Amendment Draft for Comments)
国家市场监督管理总局制止滥用行政权力排除、限制竞争行为规定 (修订草案征求意见稿)
SAMR adds new forms in which illegal acts of abusive administrative power to eliminate or restrict competition manifest / Issued: 2025-05-16
-
Secretariat of the National Technical Committee 260 on Cybersecurity of Standardization Administration of China, Guidelines for Cybersecurity Standards Practices—Requirements for Compliance Audits of Personal Information Protection (Draft for Comments)
全国网络安全标准化技术委员会秘书处网络安全标准实践指南——个人信息保护合规审计要求 (征求意见稿)
Standards are released specifying compliance audits of personal information protection / Issued: 2025-04-24
-
China Securities Regulatory Commission, Provisions for the Administration of the Deferment and Exemption of Listed Company Information Disclosures
中国证券监督管理委员会上市公司信息披露暂缓与豁免管理规定
CSRC exempts state secrets from company disclosure / CLP Reference: 2300/25.04.07 ; Promulgated: 2025-04-07 ; Effective: 2025-07-01
-
Guangzhou Development District (Huangpu District), Implementing Rules for Direct Equity Investment by Science and Technology Innovation and Venture Capital Funds of Funds
广州开发区 (黄埔区) 科技创新创业投资母基金直接股权投资实施细则
Guangzhou allows 100% loss in a seed direct investment or angel direct investment / CLP Reference: 3700/25.02.10/GZ ; Issued: 2025-02-10 ; Effective: 2025-02-10 (for three years)